 Centogene N.V. CNTG, a commercial-stage diagnostics and genetic research company, and the OESIS Network Inc, an innovation network of more than 600 schools across the U.S., today announced a partnership for COVID-19 screening of schools. The partnership will offer RT-PCR testing that can aid schools in their return to campus in the fall and continued screening to prevent a resurgence of COVID-19 over the course of the academic school year. Given the precious resources of schools public and private, the test will be offered at an affordable price and less than the COVID-19 clinical diagnostic reimbursement price announced in April for Medicare Part B for high throughput, technician intensive, and time intensive tests. 